Literature DB >> 1991349

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.

M J Daemen1, D M Lombardi, F T Bosman, S M Schwartz.   

Abstract

The present study was undertaken to explore the possibility that neointimal smooth muscle cells, the characteristic cells of restenosis and atherosclerosis, are selectively stimulated to replicate by a hypertensive stimulus. Angiotensin II (AII) was infused by osmotic minipumps for 2 weeks in 4.5-month-old rats. Group A received AII (200 ng/min) 2 weeks after a balloon catheter-induced injury of the thoracic aorta and left common carotid artery. Group B received only AII, group C only balloon denudation, and group D neither balloon injury nor AII. During the AII or Ringer's solution infusion, all animals received [3H]thymidine via a second minipump to measure DNA synthesis. AII increased the systolic pressure by more than 40 mm Hg. AII significantly increased DNA synthesis in the media of the carotid artery from 0.2 +/- 0.2% in group C to 2.5 +/- 1.5% in group A (mean +/- SD, n = 5 or 6). DNA synthesis in the neointima of the carotid artery significantly increased with AII from 4.8 +/- 4.2% in group C to 19.8 +/- 13.9% in group A. Cross-sectional area of the neointima almost doubled during AII infusion, and it increased approximately 25% in the media. Comparable results were obtained in the aorta. In a second experiment, AII was infused (125 ng/min) for 2 weeks in 11-week-old rats. Concomitantly, [3H]thymidine was given. Control rats received Ringer's solution and [3H]thymidine in their pumps. Blood pressures were elevated to the same extent as in the older animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991349     DOI: 10.1161/01.res.68.2.450

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  121 in total

1.  Dynamic Ca2+ signalling in rat arterial smooth muscle cells under the control of local renin-angiotensin system.

Authors:  Y Asada; T Yamazawa; K Hirose; T Takasaka; M Iino
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

Review 2.  Angiotensin I-converting enzyme: genotype and disease associations.

Authors:  D Crisan; J Carr
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

3.  Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion.

Authors:  Tadashi Suehiro; Tatsuhito Morita; Mari Inoue; Yoshitaka Kumon; Yukio Ikeda; Kozo Hashimoto
Journal:  Hum Genet       Date:  2004-05-26       Impact factor: 4.132

4.  Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system.

Authors:  Takehisa Suekane; Yoshihiro Ikura; Kenji Watanabe; Junko Arimoto; Yoko Iwasa; Yoshimi Sugama; Soichiro Kayo; Kenichi Sugioka; Takahiko Naruko; Kiyoshi Maeda; Kosei Hirakawa; Tetsuo Arakawa; Makiko Ueda
Journal:  J Gastroenterol       Date:  2010-04-02       Impact factor: 7.527

5.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

Authors:  M Nakajima; H G Hutchinson; M Fujinaga; W Hayashida; R Morishita; L Zhang; M Horiuchi; R E Pratt; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

Authors:  George A Makar; John H Holmes; Yu-Xiao Yang
Journal:  J Natl Cancer Inst       Date:  2014-01-15       Impact factor: 13.506

7.  TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms.

Authors:  G A Stouffer; G K Owens
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Authors:  Ke Wang; Leila R Zelnick; Peter B Imrey; Ian H deBoer; Jonathan Himmelfarb; Michael D Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Miguel A Vazquez; John W Kusek; Harold I Feldman; Gerald J Beck; Bryan Kestenbaum
Journal:  Am J Nephrol       Date:  2018-08-02       Impact factor: 3.754

9.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

Authors:  H Itoh; M Mukoyama; R E Pratt; G H Gibbons; V J Dzau
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.

Authors:  H Mitani; T Bandoh; J Ishikawa; M Kimura; T Totsuka; S Hayashi
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.